Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Other Non-Current Liabilities (2019 - 2024)

Outset Medical (OM) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $2.7 million as the latest value for Q4 2024.

  • On a quarterly basis, Other Non-Current Liabilities rose 200.78% to $2.7 million in Q4 2024 year-over-year; TTM through Dec 2024 was $2.7 million, a 200.78% increase, with the full-year FY2024 number at $2.7 million, up 200.78% from a year prior.
  • Other Non-Current Liabilities was $2.7 million for Q4 2024 at Outset Medical, up from $2.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $2.7 million in Q4 2024 to a low of $113000.0 in Q4 2022.
  • A 5-year average of $881388.9 and a median of $700500.0 in 2021 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: plummeted 84.33% in 2022, then soared 692.92% in 2023.
  • Outset Medical's Other Non-Current Liabilities stood at $240000.0 in 2020, then skyrocketed by 200.42% to $721000.0 in 2021, then tumbled by 84.33% to $113000.0 in 2022, then skyrocketed by 692.92% to $896000.0 in 2023, then surged by 200.78% to $2.7 million in 2024.
  • Per Business Quant, the three most recent readings for OM's Other Non-Current Liabilities are $2.7 million (Q4 2024), $2.2 million (Q3 2024), and $1.8 million (Q2 2024).